MicroGenDX: Advanced DNA Diagnostics for Your Infection
Are you tired of ongoing pain and discomfort from an unresolved infection? We understand your frustration! The antibiotics you've tried may not be working because your doctor relies on an old diagnostic technology called "culture." Watch this video to learn how MicroGenDX provides a more accurate, comprehensive, and effective solution powered by DNA diagnostics.
Click to watch
Why Choose MicroGenDX?
More Reliable and Accurate Testing
Standard tests may not be reliable, with many coming back as "no growth", meaning nothing was found. MicroGenDX's advanced Next-Generation-Sequencing (NGS) service identifies bacteria and fungi by their DNA with 99% accuracy so you get the answers you need.
Proven Effectiveness
Over 100 published clinical studies demonstrate the superior effectiveness of MicroGenDX testing in solving infections compared to culture, especially when they are complex, chronic or recurring.
Lightning Fast Results
You get your DNA-based diagnostic results the day after we receive your sample. One simplified report delivered faster than any NGS lab in the nation.
Not Just PCR
While many labs offer PCR testing, MicroGenDX combines it with advanced NGS, capable of detecting up to 60,000 pathogens while showing the relative abundance of each. This is crucial for treating complex infections involving multiple species.
Clinicians praise MicroGenDX for advancing diagnostics and improving treatment outcomes. The combination of qPCR+NGS provides the gold standard of DNA sequencing at the lowest cost worldwide.
"NGS is changing our understanding of microbial communities. The future in Urology involves non-culture molecular diagnostic technology like NGS."
J. Curtis Nickel, M.D., Research Chair in Urologic Pain and Inflammation at Queens University
Key Benefits of MicroGenDX qPCR+NGS Technology
Results in as little as 24hrs from sample receipt. MicroGenDX results faster than any other high capacity NGS lab in the world.
Capable of detecting up to 17 different kinds of Antimicrobial Resistance.
Better Diagnostics yield Better Outcomes. Choose a diagnostics company with years of experience testing hundreds of thousands of samples.
Mission Statement
MicroGenDX aims to improve clinical outcomes by providing clinicians and patients with the best microbial diagnostic tests. As a global leader in NGS diagnostics, we strive for continuous improvement, delivering desperately needed advances to those that need it most. NGS is the future of medical diagnostics, empowering patients and clinicians with the info they need to get and stay health.
About MicroGenDX
With over 750,000 next-gen DNA sequencing tests to date, from dozens of different countries, MicroGenDX is the global leader in NGS diagnostics. Our state-of-the-art facility and dedicated team ensure the industry's most informative microbial diagnostics for various medical specialties. We are committed to helping people with the identification of challenging infections.
MicroGenDX qPCR + NGS
Traditional Culture
Diagnostic test
qPCR+NGS performed with consistent, rapid turnaround times. (24hrs from sample receipt)
Culture performed with highly variable turnaround times (days to weeks)
Effectiveness
• 99.2% accuracy identifying all bacteria and fungi in sample, listing species by relative abundance • Antimicrobial resistance genes detected indicate potential resistance of entire
• 50% chance of “no growth” culture results • <30% accuracy at determining dominant species • Susceptibility results for single in vitro species, not resistance for entire in vivo community (biofilm/ polymicrobial)
Treatment
Research-based antimicrobials for consideration in treatment, based on the Sanford Guide and Johns Hopkins Guides
Best guess antimicrobial Rx for treatment, without diagnostic evidence to support efficacy
Outcome
Rapid, Targeted Symptom Resolution
Relive patient suffering quicker and at lower treatment cost with precision diagnostics
Repeat Office Visits
With no symptom resolution, patient suffering is prolonged and costs for treatment are increased
Timeline
* Select year to see our results
TECHNOLOGY
- Over 1.5 million molecular tests performed
CORPORATE
- Launched national TV ad campaign shown in all 50 states
KEY PUBLICATIONS
- Completed multicenter study in joint infections showing that NGS identifies infecting organisms more often than culture